Search results
Vertex (NASDAQ:VERX) PT Lowered to $34.00
ETF DAILY NEWS· 4 hours agoVertex (NASDAQ:VERX – Get Free Report) had its target price dropped by research analysts at Bank of America from $40.00 to $34.00 in a research note issued on Tuesday, Benzinga ...
Vertex (NASDAQ:VERX) Shares Gap Down on Analyst Downgrade
ETF DAILY NEWS· 5 hours agoShares of Vertex, Inc. (NASDAQ:VERX – Get Free Report) gapped down prior to trading on Tuesday after Citigroup lowered their price target on the stock from $34.00 to $32.00 ...
Vertex Selected to Join Oracle ISV Accelerator for SaaS Initiative
Morningstar· 18 hours agoVertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions and a member of Oracle PartnerNetwork (OPN), today ...
Vertex, Inc. Announces Pricing of Upsized $300 Million Convertible Senior Notes Offering - Vertex...
Benzinga· 1 day agoVertex, Inc. VERX ("Vertex"), a leading global provider of indirect tax solutions, today announced the pricing of $300 million aggregate principal amount ...
Brokers Set Expectations for Vertex Pharmaceuticals Incorporated’s Q3 2025 Earnings (NASDAQ:VRTX)
ETF DAILY NEWS· 1 day agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Equities research analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Vertex ...
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoVertex Pharmaceuticals (NASDAQ: VRTX) has long been known for its expertise in treating cystic...
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Zacks via Yahoo Finance· 2 days agoVertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem...
Vertex has top orphan drug in the pipeline, as pharma eyes shiny obesity drugs: report
FierceBiotech· 1 day agoVertex’s cystic fibrosis triple combo is poised to become the top selling orphan drug in terms of...
Vertex (NASDAQ:VERX) Given “Market Outperform” Rating at JMP Securities
ETF DAILY NEWS· 1 day agoJMP Securities reaffirmed their market outperform rating on shares of Vertex (NASDAQ:VERX – Free Report) in a research report released on Tuesday morning, Benzinga reports ...
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 6 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...